ICD-10 CM Codes that support Medical Necessity for CPT Code 86003 Part 02

T36.3X5A Adverse effect of macrolides, initial encounter
T36.3X5S Adverse effect of macrolides, sequela
T36.3X5D Adverse effect of macrolides, subsequent encounter
T40.3X5A Adverse effect of methadone, initial encounter
T40.3X5S Adverse effect of methadone, sequela
T40.3X5D Adverse effect of methadone, subsequent encounter
T43.635A Adverse effect of methylphenidate, initial encounter
T43.635S Adverse effect of methylphenidate, sequela
T43.635D Adverse effect of methylphenidate, subsequent encounter
T50.0X5A Adverse effect of mineralocorticoids and their antagonists, initial encounter
T50.0X5S Adverse effect of mineralocorticoids and their antagonists, sequela
T50.0X5D Adverse effect of mineralocorticoids and their antagonists, subsequent encounter
T42.5X5A Adverse effect of mixed antiepileptics, initial encounter
T42.5X5S Adverse effect of mixed antiepileptics, sequela
T42.5X5D Adverse effect of mixed antiepileptics, subsequent encounter
T50.A25A Adverse effect of mixed bacterial vaccines without a pertussis component, initial encounter
T50.A25S Adverse effect of mixed bacterial vaccines without a pertussis component, sequela
T50.A25D Adverse effect of mixed bacterial vaccines without a pertussis component, subsequent encounter
T43.1X5A Adverse effect of monoamine-oxidase-inhibitor antidepressants, initial encounter
T43.1X5S Adverse effect of monoamine-oxidase-inhibitor antidepressants, sequela
T43.1X5D Adverse effect of monoamine-oxidase-inhibitor antidepressants, subsequent encounter
T49.5X5A Adverse effect of ophthalmological drugs and preparations, initial encounter
T49.5X5S Adverse effect of ophthalmological drugs and preparations, sequela
T49.5X5D Adverse effect of ophthalmological drugs and preparations, subsequent encounter
T40.0X5A Adverse effect of opium, initial encounter
T40.0X5S Adverse effect of opium, sequela
T40.0X5D Adverse effect of opium, subsequent encounter
T38.4X5A Adverse effect of oral contraceptives, initial encounter
T38.4X5S Adverse effect of oral contraceptives, sequela
T38.4X5D Adverse effect of oral contraceptives, subsequent encounter
T48.995A Adverse effect of other agents primarily acting on the respiratory system, initial encounter
T48.995S Adverse effect of other agents primarily acting on the respiratory system, sequela
T48.995D Adverse effect of other agents primarily acting on the respiratory system, subsequent encounter
T47.8X5A Adverse effect of other agents primarily affecting gastrointestinal system, initial encounter
T47.8X5S Adverse effect of other agents primarily affecting gastrointestinal system, sequela
T47.8X5D Adverse effect of other agents primarily affecting gastrointestinal system, subsequent encounter
T46.995A Adverse effect of other agents primarily affecting the cardiovascular system, initial encounter
T46.995S Adverse effect of other agents primarily affecting the cardiovascular system, sequela
T46.995D Adverse effect of other agents primarily affecting the cardiovascular system, subsequent encounter
T47.1X5A Adverse effect of other antacids and anti-gastric-secretion drugs, initial encounter
T47.1X5S Adverse effect of other antacids and anti-gastric-secretion drugs, sequela
T47.1X5D Adverse effect of other antacids and anti-gastric-secretion drugs, subsequent encounter
T48.5X5A Adverse effect of other anti-common-cold drugs, initial encounter
T48.5X5S Adverse effect of other anti-common-cold drugs, sequela
T48.5X5D Adverse effect of other anti-common-cold drugs, subsequent encounter
T43.295A Adverse effect of other antidepressants, initial encounter
T43.295S Adverse effect of other antidepressants, sequela
T43.295D Adverse effect of other antidepressants, subsequent encounter
T46.2X5A Adverse effect of other antidysrhythmic drugs, initial encounter
T46.2X5S Adverse effect of other antidysrhythmic drugs, sequela
T46.2X5D Adverse effect of other antidysrhythmic drugs, subsequent encounter
T42.6X5A Adverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter
T42.6X5S Adverse effect of other antiepileptic and sedative-hypnotic drugs, sequela
T42.6X5D Adverse effect of other antiepileptic and sedative-hypnotic drugs, subsequent encounter
T46.5X5A Adverse effect of other antihypertensive drugs, initial encounter
T46.5X5S Adverse effect of other antihypertensive drugs, sequela
T46.5X5D Adverse effect of other antihypertensive drugs, subsequent encounter
T37.3X5A Adverse effect of other antiprotozoal drugs, initial encounter
T37.3X5S Adverse effect of other antiprotozoal drugs, sequela
T37.3X5D Adverse effect of other antiprotozoal drugs, subsequent encounter
T43.595A Adverse effect of other antipsychotics and neuroleptics, initial encounter
T43.595S Adverse effect of other antipsychotics and neuroleptics, sequela
T43.595D Adverse effect of other antipsychotics and neuroleptics, subsequent encounter
T50.A95A Adverse effect of other bacterial vaccines, initial encounter
T50.A95S Adverse effect of other bacterial vaccines, sequela
T50.A95D Adverse effect of other bacterial vaccines, subsequent encounter
T44.995A Adverse effect of other drug primarily affecting the autonomic nervous system, initial encounter
T44.995S Adverse effect of other drug primarily affecting the autonomic nervous system, sequela
T44.995D Adverse effect of other drug primarily affecting the autonomic nervous system, subsequent encounter
T48.295A Adverse effect of other drugs acting on muscles, initial encounter
T48.295S Adverse effect of other drugs acting on muscles, sequela
T48.295D Adverse effect of other drugs acting on muscles, subsequent encounter
T50.995A Adverse effect of other drugs, medicaments and biological substances, initial encounter
T50.995S Adverse effect of other drugs, medicaments and biological substances, sequela
T50.995D Adverse effect of other drugs, medicaments and biological substances, subsequent encounter
T38.5X5A Adverse effect of other estrogens and progestogens, initial encounter
T38.5X5S Adverse effect of other estrogens and progestogens, sequela
T38.5X5D Adverse effect of other estrogens and progestogens, subsequent encounter
T45.695A Adverse effect of other fibrinolysis-affecting drugs, initial encounter
T45.695S Adverse effect of other fibrinolysis-affecting drugs, sequela
T45.695D Adverse effect of other fibrinolysis-affecting drugs, subsequent encounter
T41.295A Adverse effect of other general anesthetics, initial encounter
T41.295S Adverse effect of other general anesthetics, sequela
T41.295D Adverse effect of other general anesthetics, subsequent encounter
T38.995A Adverse effect of other hormone antagonists, initial encounter
T38.995S Adverse effect of other hormone antagonists, sequela
T38.995D Adverse effect of other hormone antagonists, subsequent encounter
T38.895A Adverse effect of other hormones and synthetic substitutes, initial encounter
T38.895S Adverse effect of other hormones and synthetic substitutes, sequela
T38.895D Adverse effect of other hormones and synthetic substitutes, subsequent encounter
T47.4X5A Adverse effect of other laxatives, initial encounter
T47.4X5S Adverse effect of other laxatives, sequela
T47.4X5D Adverse effect of other laxatives, subsequent encounter
T40.695A Adverse effect of other narcotics, initial encounter
T40.695S Adverse effect of other narcotics, sequela
T40.695D Adverse effect of other narcotics, subsequent encounter
T39.8X5A Adverse effect of other nonopioid analgesics and antipyretics, not elsewhere classified, initial encounter
T39.8X5S Adverse effect of other nonopioid analgesics and antipyretics, not elsewhere classified, sequela
T39.8X5D Adverse effect of other nonopioid analgesics and antipyretics, not elsewhere classified, subsequent encounter
T39.395A Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter
T39.395S Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], sequela
T39.395D Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], subsequent encounter
T40.2X5A Adverse effect of other opioids, initial encounter
T40.2X5S Adverse effect of other opioids, sequela
T40.2X5D Adverse effect of other opioids, subsequent encounter
T44.3X5A Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter
T44.3X5S Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, sequela
T44.3X5D Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, subsequent encounter
T44.1X5A Adverse effect of other parasympathomimetics [cholinergics], initial encounter
T44.1X5S Adverse effect of other parasympathomimetics [cholinergics], sequela
T44.1X5D Adverse effect of other parasympathomimetics [cholinergics], subsequent encounter
T45.8X5A Adverse effect of other primarily systemic and hematological agents, initial encounter
T45.8X5S Adverse effect of other primarily systemic and hematological agents, sequela
T45.8X5D Adverse effect of other primarily systemic and hematological agents, subsequent encounter
T40.995A Adverse effect of other psychodysleptics [hallucinogens], initial encounter
T40.995S Adverse effect of other psychodysleptics [hallucinogens], sequela
T40.995D Adverse effect of other psychodysleptics [hallucinogens], subsequent encounter
T43.695A Adverse effect of other psychostimulants, initial encounter
T43.695S Adverse effect of other psychostimulants, sequela
T43.695D Adverse effect of other psychostimulants, subsequent encounter
T43.8X5A Adverse effect of other psychotropic drugs, initial encounter
T43.8X5S Adverse effect of other psychotropic drugs, sequela
T43.8X5D Adverse effect of other psychotropic drugs, subsequent encounter
T37.8X5A Adverse effect of other specified systemic anti-infectives and antiparasitics, initial encounter
T37.8X5S Adverse effect of other specified systemic anti-infectives and antiparasitics, sequela
T37.8X5D Adverse effect of other specified systemic anti-infectives and antiparasitics, subsequent encounter
T40.4X5A Adverse effect of other synthetic narcotics, initial encounter
T40.4X5S Adverse effect of other synthetic narcotics, sequela
T40.4X5D Adverse effect of other synthetic narcotics, subsequent encounter
T36.8X5A Adverse effect of other systemic antibiotics, initial encounter
T36.8X5S Adverse effect of other systemic antibiotics, sequela
T36.8X5D Adverse effect of other systemic antibiotics, subsequent encounter
T49.8X5A Adverse effect of other topical agents, initial encounter
T49.8X5S Adverse effect of other topical agents, sequela
T49.8X5D Adverse effect of other topical agents, subsequent encounter
T50.Z95A Adverse effect of other vaccines and biological substances, initial encounter
T50.Z95S Adverse effect of other vaccines and biological substances, sequela
T50.Z95D Adverse effect of other vaccines and biological substances, subsequent encounter
T50.B95A Adverse effect of other viral vaccines, initial encounter
T50.B95S Adverse effect of other viral vaccines, sequela
T50.B95D Adverse effect of other viral vaccines, subsequent encounter
T49.6X5A Adverse effect of otorhinolaryngological drugs and preparations, initial encounter
T49.6X5S Adverse effect of otorhinolaryngological drugs and preparations, sequela
T49.6X5D Adverse effect of otorhinolaryngological drugs and preparations, subsequent encounter
T48.0X5A Adverse effect of oxytocic drugs, initial encounter
T48.0X5S Adverse effect of oxytocic drugs, sequela
T48.0X5D Adverse effect of oxytocic drugs, subsequent encounter
T36.0X5A Adverse effect of penicillins, initial encounter
T36.0X5S Adverse effect of penicillins, sequela
T36.0X5D Adverse effect of penicillins, subsequent encounter
T46.7X5A Adverse effect of peripheral vasodilators, initial encounter
T46.7X5S Adverse effect of peripheral vasodilators, sequela
T46.7X5D Adverse effect of peripheral vasodilators, subsequent encounter
T50.A15A Adverse effect of pertussis vaccine, including combinations with a pertussis component, initial encounter
T50.A15S Adverse effect of pertussis vaccine, including combinations with a pertussis component, sequela
T50.A15D Adverse effect of pertussis vaccine, including combinations with a pertussis component, subsequent encounter
T43.3X5A Adverse effect of phenothiazine antipsychotics and neuroleptics, initial encounter
T43.3X5S Adverse effect of phenothiazine antipsychotics and neuroleptics, sequela
T43.3X5D Adverse effect of phenothiazine antipsychotics and neuroleptics, subsequent encounter
T44.4X5A Adverse effect of predominantly alpha-adrenoreceptor agonists, initial encounter
T44.4X5S Adverse effect of predominantly alpha-adrenoreceptor agonists, sequela
T44.4X5D Adverse effect of predominantly alpha-adrenoreceptor agonists, subsequent encounter
T44.5X5A Adverse effect of predominantly beta-adrenoreceptor agonists, initial encounter
T44.5X5S Adverse effect of predominantly beta-adrenoreceptor agonists, sequela
T44.5X5D Adverse effect of predominantly beta-adrenoreceptor agonists, subsequent encounter
T39.315A Adverse effect of propionic acid derivatives, initial encounter
T39.315S Adverse effect of propionic acid derivatives, sequela
T39.315D Adverse effect of propionic acid derivatives, subsequent encounter
T39.2X5A Adverse effect of pyrazolone derivatives, initial encounter
T39.2X5S Adverse effect of pyrazolone derivatives, sequela
T39.2X5D Adverse effect of pyrazolone derivatives, subsequent encounter
T36.6X5A Adverse effect of rifampicins, initial encounter
T36.6X5S Adverse effect of rifampicins, sequela
T36.6X5D Adverse effect of rifampicins, subsequent encounter
T39.095A Adverse effect of salicylates, initial encounter
T39.095S Adverse effect of salicylates, sequela
T39.095D Adverse effect of salicylates, subsequent encounter
T47.3X5A Adverse effect of saline and osmotic laxatives, initial encounter
T47.3X5S Adverse effect of saline and osmotic laxatives, sequela
T47.3X5D Adverse effect of saline and osmotic laxatives, subsequent encounter
T43.215A Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, initial encounter
T43.215S Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, sequela
T43.215D Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, subsequent encounter
T43.225A Adverse effect of selective serotonin reuptake inhibitors, initial encounter
T43.225S Adverse effect of selective serotonin reuptake inhibitors, sequela
T43.225D Adverse effect of selective serotonin reuptake inhibitors, subsequent encounter
T48.1X5A Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter
T48.1X5S Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], sequela
T48.1X5D Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], subsequent encounter
T50.B15A Adverse effect of smallpox vaccines, initial encounter
T50.B15S Adverse effect of smallpox vaccines, sequela
T50.B15D Adverse effect of smallpox vaccines, subsequent encounter
T47.2X5A Adverse effect of stimulant laxatives, initial encounter
T47.2X5S Adverse effect of stimulant laxatives, sequela
T47.2X5D Adverse effect of stimulant laxatives, subsequent encounter
T42.2X5A Adverse effect of succinimides and oxazolidinediones, initial encounter
T42.2X5S Adverse effect of succinimides and oxazolidinediones, sequela
T42.2X5D Adverse effect of succinimides and oxazolidinediones, subsequent encounter
T37.0X5A Adverse effect of sulfonamides, initial encounter
T37.0X5S Adverse effect of sulfonamides, sequela
T37.0X5D Adverse effect of sulfonamides, subsequent encounter
T43.025A Adverse effect of tetracyclic antidepressants, initial encounter
T43.025S Adverse effect of tetracyclic antidepressants, sequela
T43.025D Adverse effect of tetracyclic antidepressants, subsequent encounter
T36.4X5A Adverse effect of tetracyclines, initial encounter
T36.4X5S Adverse effect of tetracyclines, sequela
T36.4X5D Adverse effect of tetracyclines, subsequent encounter
T41.5X5A Adverse effect of therapeutic gases, initial encounter
T41.5X5S Adverse effect of therapeutic gases, sequela
T41.5X5D Adverse effect of therapeutic gases, subsequent encounter
T45.615A Adverse effect of thrombolytic drugs, initial encounter
T45.615S Adverse effect of thrombolytic drugs, sequela
T45.615D Adverse effect of thrombolytic drugs, subsequent encounter
T38.1X5A Adverse effect of thyroid hormones and substitutes, initial encounter
T38.1X5S Adverse effect of thyroid hormones and substitutes, sequela
T38.1X5D Adverse effect of thyroid hormones and substitutes, subsequent encounter
T43.015A Adverse effect of tricyclic antidepressants, initial encounter
T43.015S Adverse effect of tricyclic antidepressants, sequela
T43.015D Adverse effect of tricyclic antidepressants, subsequent encounter
T48.905A Adverse effect of unspecified agents primarily acting on the respiratory system, initial encounter
T48.905S Adverse effect of unspecified agents primarily acting on the respiratory system, sequela
T48.905D Adverse effect of unspecified agents primarily acting on the respiratory system, subsequent encounter
T46.905A Adverse effect of unspecified agents primarily affecting the cardiovascular system, initial encounter
T46.905S Adverse effect of unspecified agents primarily affecting the cardiovascular system, sequela
T46.905D Adverse effect of unspecified agents primarily affecting the cardiovascular system, subsequent encounter
T47.95XA Adverse effect of unspecified agents primarily affecting the gastrointestinal system, initial encounter
T47.95XS Adverse effect of unspecified agents primarily affecting the gastrointestinal system, sequela
T47.95XD Adverse effect of unspecified agents primarily affecting the gastrointestinal system, subsequent encounter
T41.45XA Adverse effect of unspecified anesthetic, initial encounter